Popular search terms:
Search Results Label
57 results found-
Seqirus announces major advances in pandemic preparedness
Seqirus announced today that the accelerated development of cell-based manufacturing technology at its manufacturing facility in Holly Springs, North Carolina, has delivered a four-fold increase in seasonal influenza vaccine output in just two years, strengthening the United States' capacity to respond to pandemic threats.
https://www.seqirus.com/...advances-in-pandemic-preparedness -
Seqirus | Influenza Expertise
Seqirus brings multifaceted expertise to influenza prevention, employing both egg and cell-based technologies to meet the global community's needs.
https://www.seqirus.com/expertise -
Seqirus announces next major advancement in cell-based influenza
In an industry first, Seqirus has successfully produced cell-based influenza vaccine at commercial scale using a candidate vaccine virus (CVV) that has been isolated and grown in cells, rather than in eggs.
https://www.seqirus.com/...ased-influenza-vaccine-technology -
Seqirus | A World Leader in Influenza Vaccines
Learn more about how we're leveraging cutting-edge technology and proven expertise to develop influenza vaccines and respond to pandemic threats.
https://www.seqirus.com/ -
Seqirus | Global Manufacturing Network
Seqirus is one of the largest influenza vaccine companies in the world, with state-of-the-art manufacturing facilities on three continents. Learn more.
https://www.seqirus.com/...ring/global-manufacturing-network -
Seqirus | Influenza Pandemic Response Solutions
Seqirus has been on the front line of pandemic preparedness for more than a century. Learn more about our rapid vaccine production capabilities.
https://www.seqirus.com/...uenza/pandemic-response-solutions -
Seqirus Joining UIVI to Advance Universal Flu Vaccine Research
Seqirus, a global leader in the prevention of influenza, announced today that Seqirus is joining the Project's Universal Influenza Vaccine Initiative (UIVI).
https://www.seqirus.com/...ce-universal-flu-vaccine-research -
Seqirus | Partnership Opportunities
Seqirus stands with our partners on the front line of public health. We are the largest fully integrated commercialisation partner in Australia and New Zealand. Learn more.
https://www.seqirus.com/partnering -
Seqirus | Research & Development Efforts
Seqirus is working tirelessly to optimise our technology and implement transformational long-term approaches to influenza pandemic preparedness.
https://www.seqirus.com/r-and-d -
Seqirus Presents New Clinical Data Reinforcing MF59
Read the latest news from Seqirus, a world leader in developing and producing influenza vaccines.
https://www.seqirus.com/...ew-clinical-data-reinforcing-mf59